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Abstract
Allelic mutations of Scn8a in the mouse have revealed the range of neurological disorders that can result
from alternations of one neuronal sodium channel. Null mutations produce the most severe phenotype,
with motor neuron failure leading to paralysis and juvenile lethality. Two less severe mutations cause
ataxia, tremor, muscle weakness, and dystonia. The electrophysiological effects have been studied at the
cellular level by recording from neurons from the mutant mice. The data demonstrate that Scn8a is required
for the complex spiking of cerebellar Purkinje cells and for persistent sodium current in several classes of
neurons, including some with pacemaker roles. The mouse mutations of Scn8a have also provided insight
into the mode of inheritance of channelopathies, and led to the identification of a modifier gene that affects
transcript splicing. These mutations demonstrate the value of mouse models to elucidate the pathophysi-
ology of human disease.
Overview
The spontaneous mouse neurological mutant
‘motor endplate disease’ (med) arose in 1958 at the
University of Edinburgh (Duchen, Searle & Strich,
1967). This autosomal recessive mutation resulted
in muscle atrophy, paralysis and death. Two allelic
mutations were later identified at the Jackson
Laboratory, medJ and jolting (Sidman, Cowen &
Eicher, 1979). Elegant morpholgical, physiological
and electrophysiological studies in the laboratories
of Duchen and Harris in the 1970s and 1980s led
to the prediction that the mutation affected an ion
channel gene involved in release of neurotrans-
mitter from the nerve terminals of motor neurons.
In 1992, an insertional mutation with a similar
phenotype was discovered by Brett Spear at the
University of Kentucky. We demonstrated allelism
of the new mutation by noncomplementation with
medJ, and demonstrated that the disrupted gene
was a novel neuronal sodium channel (Burgess
et al., 1995; Kohrman et al., 1995). Fortunately,
the first three alleles had been preserved, and Dave
Kohrman went on to identify the molecular lesions
in all three alleles (Kohrman, Harris & Meisler,
1996a; Kohrman et al., 1996b). The Scn8a allele
series provides the first demonstration of the
in vivo physiological and clinical consequences of
mutations in a neuronal sodium channel gene. In
addition to the visible neurological disorders,
electrophysiological studies of neurons isolated
from these mice have revealed some of the unique
cellular functions of the Scn8a channel. The phe-
notypes of the mouse mutants provide a prediction
of the types of human patients that may carry
mutations in voltage gated sodium channels. The
first such mutation was found in our laboratory
earlier this year (Trudeau et al., 2000). The Scn8a
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allele series demonstrates the heterogeneity of
disorders resulting from different mutations in a
single gene, and illustrate the value of multiple
alleles for elucidating cellular and physiological
function.
The voltage-gated sodium channel a subunit gene
family
The voltage-gated sodium channels are responsible
for the rising phase of the action potential in
neurons and muscle cells. The mammalian genome
contains 10 closely related sodium channel genes
with highly conserved protein sequence but diver-
gent tissue-specific expression. These genes are
located in four paralogous chromosome segments
that also contain the HOX gene clusters (Plummer
& Meisler, 1999). Four of the sodium channel
genes are expressed at a high level in the central
nervous system (CNS): SCN1A, SCN2A, SCN3A,
and SCN8A. Most neurons in the CNS appear to
express all of these channels, albeit in different
proportions. Although their in vitro channel bio-
chemical activities are very similar, null alleles of
Scn1a, Scn2a and Scn8a in the mouse are all lethal,
demonstrating that they are not functionally
redundant in vivo (Burgess et al., 1995; Planells-
Cases et al., 2000; W. Catterall, pers. commun.).
Analysis of rescue by chimeric channels may pro-
vide insight into the unique functions associated
with each family member. Physiological studies of
these mice will be essential for understanding the
role of each channel in the intact nervous system.
Characteristics of sodium channel SCN8A
SCN8A is one of the most abundant voltage-gated
sodium channels in the brain (Schaller et al., 1995),
and is the major channel at the nodes of Ranvier in
mature myelinated axons (Caldwell et al., 2000;
Krzemien et al., 2000; Schaller & Caldwell, 2000;
Tzoumaka et al., 2000). Additional sites of sub-
cellular localization in the CNS include dendrites,
presynaptic and postsynaptic membranes, and
nonmyelinated axons. Because it is found at syn-
apses, modulation of SCN8A activity by genetic
variation or physiological modification may be
expected to influence synaptic strength, learning
and memory.
An insertional allele of the Scn8a locus, Scn8atg
The insertional mutation of Scn8a arose during a
long-term study of expression of the alpha feto-
protein promoter in transgenic mice (Spear, 1994;
Ramesh, Ellis & Spear, 1995). Homozygous trans-
genic mice of one line, A4, exhibited a neurological
syndrome that began with abnormal gait at
2 weeks of age and led to paralysis and death by
3 weeks of age. The new mutation was genetically
mapped approximately 10 cM distal to the posi-
tion of the med locus on the consensus map of
mouse chromosome 15 (Kohrman et al., 1995).
Because of the similarity in the phenotypes of A4
and med, we tested for alleleism by crossing A4
transgenic heterozygotes with heterozygous med J
mice from the frozen embryo bank at The Jackson
Laboratory. The expected frequency of 25% of
compound heterozygote offspring were recovered
in the F2, and these animals displayed the typical
med phenotype, demonstrating that the new
mutation was allelic with med J.
Cloning of the Scn8a gene
To identify the mutated gene, we generated a
cosmid library of genomic DNA from Scn8atg
homozygotes and screened it by hybridization with
the transgene; the methods were described (Meisler
et al., 1997) and are still appropriate for the iso-
lation of new insertional mutants. Junction clones
containing both transgene and adjacent DNA
from the insertion site were analyzed and found to
contain exons from a novel sodium channel
(Burgess et al., 1995). A deletion of £20 kb in the
middle of the Scn8a gene removed several exons
and inactivated the gene.
The human ortholog of the new gene, SCN8A,
was isolated and mapped to a conserved linkage
group on chromosome 12q13 (Burgess et al.,
1995). The structure and sequence of the human
gene have been determined (Plummer et al., 1998).
The orthologous rat cDNA was independently
isolated in 1995 (Schaller et al., 1995), and the
human cDNA was subsequently isolated from
dorsal root ganglion neurons (Dietrich et al.,
1998). This channel has been variously designated
NaCh6, CerIII and PN4; the new recommended
nomenclature is Nav1.6.
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The original med mutation is a null allele of Scn8a
The original med line and the jolting allele were
maintained by Dr John Harris at the Neuro-
muscular Disease Unit in Newcastle, UK, for
more than 20 years, and he kindly provided
breeding pairs. Analysis by RT-PCR and
genomic sequencing demonstrated that the ori-
ginal med mutation was caused by insertion of
a transposable L1 element into exon 2 (Fig-
ure 1). Aberrant splicing of the mutant tran-
script disrupts the open reading frame and
truncates the protein close to the N-terminus
(Kohrman, Harris & Meisler, 1996a). Thus both
the original allele and the transgene insertion
allele are nulls, and exhibit identical phenotypes
(Table 1).
Failure of motor nerve function in Scn8a null mice
results in juvenile lethality
Homozygous Scn8amed and Scn8amedtgmice develop
severe muscle atrophy, weakness, and progressive
paralysis that begins in the hind limbs. Between 17
and 23 days of age, the sciatic nerve exhibits re-
duced conduction velocity, prolonged refractory
period, and widening of the non-myelinated gaps
at the nodes of Ranvier (Agnaut-Petit et al., 1982;
Rieger et al., 1984; Bournaud et al., 1987; Fücht-
bauer, 1987; Kearney, 2002). These changes are
accompanied by failure of transmission at the
neuromuscular junction, with somewhat faster
progression in biceps than in triceps (Duchen &
Stefani, 1971). Terminal sprouting of the motor
nerves, muscle fiber atrophy, and appearance of
central nuclei indicative of fiber regeneration
(Duchen, Searle & Strich, 1967; Duchen & Stefani,
1971) demonstrate that the motor neurons do not
properly innervate the muscle in homozygous null
mice, which do not survive beyond 1 month of
age.
The severe phenotype and hind limb paralysis
of the null mutants can be understood in the light
of recent evidence that Scn8a is the major channel
at the nodes of Ranvier (Caldwell et al., 2000). The
total sodium current of motor neurons increases
three fold during the first week of life in normal
mice, and most of this increase appears to be due
to Scn8a, since there was no increase in Scn8a null
mice (Garcia et al., 1998). Scn8a is also the major
nodal channel in nerves innervating the diaphragm
muscle, and paralysis of the diaphragm may be the
cause of death. Because of the early lethality, the
null mutant cannot be used to study the effects of
Scn8a deficiency in adult brain. Heterozygotes for
the null mutations are phenotypically normal,
demonstrating that 50% of normal levels of Scn8a
is adequate.
A hypomorphic allele of Scn8a results in severe
muscle weakness and dystonic postures
The med J mutation arose 30 years ago at the
Jackson Laboratory in a linkage stock carrying
the closely linked visible marker Caracul (Ca). A
4 bp deletion in the splice donor site of intron 3
results in abnormal splicing and skipping of ex-
ons 2 and 3 (Kohrman, Harris & Meisler,
Figure 1. Positions of four allelic mutations of the mouse sodium channel Scn8a. The voltage-gated sodium channels contain four
homologous domains (D1 to D4) each with six transmembrane segments (S1 to S6). The domains are separated by cytoplasmic loops
and a short inactivation linker. The sequences of the transmembrane domains are more conserved than the cytoplasmic loops. The
positively charged S4 segments act as voltage sensors and move outward from the membrane in response to depolarization. The
associated transmembrane b1 and b2 subunits are also shown.
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1996a). The resulting protein is truncated in
Domain 1 (Figure 1). However, Scn8amedJ is not
a true null allele because approximately 12% of
the transcripts are correctly spliced (Kearney et
al., 2002). This low level of expression prevents
paralysis, but homozygotes have severe muscle
weakness and cannot support their own weight.
They also exhibit frequent episodes of sustained
abnormal postures of the limbs and body
(Sprunger et al., 1999). These dystonic postures
persist for periods from 5 to 10 s in young ani-
mals, and for several minutes in older animals.
An example is shown in Figure 2, left panel.
These postures resemble human dystonia, al-
though it is not known whether the pathogenesis
is of central or peripheral origin. Imbalance in
the strength of flexor and extensor muscles could
be responsible, but abnormal currents in higher
centers of motor control may also contribute the
dystonic phenotype. A ‘floxed’ allele of Scn8a
has been developed, in order to resolve these
alternatives using tissue specific inactivation of
the channel (S. Levin & M. Meisler, genesis
2004). Inactivation of Scn8a in cerebellar Pur-
kinje cells reproduces a subset of the null phe-
notype (manuscript in preparation).
A missense mutation of Scn8a results in tremor
and ataxia
The jolting mutation arose at the Jackson Labo-
ratory in 1965 (Sidman, Cowen & Eicher, 1979). A
single nucleotide change results in an alanine to
threonine substitution in an evolutionarily con-
served cytoplasmic linker domain (Figure 1) (Ko-
hrman et al., 1996b). This mutation causes a
14 mV positive shift in the voltage dependence of
activation of the channel (Kohrman et al., 1996b;
Smith & Goldin, 1999). Scn8a jo homozygotes have
chronic ataxia with an unsteady, wide-based gait,
as well as a rhythmical tremor of head and neck
that is induced by attempted movement (Dick,
Boakes & Harris, 1985). Neuromuscular trans-
mission is normal, and the mice are fertile and
have a normal lifespan. Cerebellar Purkinje cells
show a lack of spontaneous activity and there is
progressive loss of Purkinje cells after 6 months of
age (Dick, Boakes & Harris, 1985; Harris, Boakes
& Court, 1992; see below). The characteristics


































































































































































































































































































































































































































































































































Scn8a is essential for complex spiking
in cerebellar Purkinje cells
The most striking cellular effect of the Scn8a
mutations described to date is the effect on cere-
bellar Purkinje cells. These cells are distinguished
by their spontaneous slow firing pattern and their
ability to generate a series of action potentials after
stimulation. This complex spiking activity is
thought to be involved in integration of signals for
motor control. Recordings of currents from Pur-
kinje cells demonstrate loss of complex spiking in
both Scn8atg and Scn8a jo mice (Figure 3, right
panel). The similar effect of the null and the mis-
sense mutation indicates that the Purkinje cell is
particularly dependent on Scn8a. This functional
requirement is consistent with the high level of
Scn8a expression that was detected in Purkinje cells
(Schaller et al., 1995; Krzemien et al., 2000). Scn8a
mutations also affect two other characteristic
Figure 2. A modifier gene alters the clinical consequences of low levels of Scn8a in homozygous medJ mice. The 8 month old
homozyogte on strain C3H exhibits muscle weakness and dystonic postures. The 3 weeks old animal on strain C57BL/6J is paralyzed.
The difference is caused by the Scnm1 modifier locus on chromosome 3.
Figure 3. Two characteristic currents of cerebellar Purkinje cells are reduced in mice with mutation in Scn8a. Left, resurgent current
and persistent currents; right, complex spiking. Reprinted from Raman et al. (1997) with permission of the publisher.
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sodium currents of Purkinje cells, the persistent
current and the resurgent current (Figure 3, left
panel) (Raman et al., 1997). It is interesting that the
small change in voltage dependence of Scn8a jo has
a profound effect on currents in Purkinje cells but
does not impair the generation of action potentials
in motor neurons.
Cartwheel cells of the dorsal cochlear nucleus
are ontologically related to cerebellar Purkinje
cells and exibit similar firing patterns. Currents
recorded from the dorsal cochlear nucleus in brain
slices from Scn8a medJ and Scn8a jo mice demon-
strated extensive loss of these cells as well (Chen
et al., 1999). Persistent current is a feature of many
pacemaker neurons and pyramidal cortical cells,
and the med mutants alter these as well (Raman
et al., 1997; Maurice et al., 2001).
Threshold quantitative requirement for SCN8A:
how much is enough?
For most enzyme deficiencies, a few percent of
normal activity is sufficient to prevent disease, but
for structural proteins like collagen, haploinsuffi-
ciency is common. We generated mice with various
levels of Scn8a by combining different alleles
(Table 2). The results suggest that the critical
threshold for survival is between 6 and 12% of
normal levels, and the threshold for normal
movement is between 12 and 50% of the normal
concentration.
Dominant or recessive inheritance of sodium
channel mutations
The mode of inheritance of ion channel mutations
is determined by the nature of the channel defect
and the function of the mixed channel population
in heterozygous cells. Sodium channel a subunits
function as monomers. Many human mutations in
ion channels result in incomplete inactivation of
the channel and are inherited as dominant disor-
ders (Bulman, 1997). In contrast, the Scn8a alleles
in the mouse are recessive. This can be understood
in terms of the functional effects of each allele.
Scn8a jo encoded channels require an extra 14 mV
of depolarization before the channel is activated.
In heterozygotes, the wildtype channels activate at
normal voltage and can initiate the action poten-
tial. Thus both types of inheritance may occur,
depending on the functional characteristics of the
mutant protein.
Digenic inheritance: an unlinked modifier
locus of the hypomorphic Scn8amedJ allele
The influence of secondary genetic factors on the
severity of human monogenic disorders is becom-
ing increasingly evident (Dipple & McCabe, 2000).
Inbred strains of mice carry different alleles at
many loci. Interacting genes that modify a mutant
phenotype may be identified by crossing a mutant
onto different strains. The Scn8amedJ mutation has
been tested on five strain backgrounds. Muscle
weakness and dystonic postures were observed on
four strains: C3H, DBA, A/J and 129/SvJ (Fig-
ure 2, left panel). However, on strain C57BL/6J,
Scn8amedJ homozygotes mimic null homozygotes
and do not survive (Figure 2, right panel). A
modifier gene on chromosome 3, designated so-
dium channel modifier 1 (Scnm1), co-segregates
with lethality in crosses between C57BL/6J and
each of the other strains (Sprunger et al., 1999,
Buchner et al., 2003a). Thus C57BL/6J appears to
carry a unique, susceptible allele of the modifier
Scnm1. The orthologous human chromosome
band 1q21 is a gene-dense region containing sev-
eral genes with neuronal functions. We used
positional cloning to identify this novel gene and
its mechanism of interaction with Scn8a (Buchner,
Trudeau & Meisler, 2003b). The modifier gene
encodes an U1C zinc finger protein with nuclear
localization that acts on the medJ transcript to
increase the proportion of correctly spliced tran-
scripts. The isolation of SCNM1 is one of the first
demonstrations of the mechanism of interaction of
a modifier gene with a primary disease gene.





med J /med J 12% Dystonia, muscle
weakness
med J/) 6% Lethal
)/) 0 Lethal
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Insights from multiple alleles of Scn8a
If we had been limited to analysis of a null allele of
Scn8a, we would not have guessed that mutations
in this gene could result in tremor, ataxia, or
dystonia, all serious human medical concerns. We
would also have been unable to study the role of
the channel in the adult nervous system. Within
the next few years we anticipate a significant in-
crease in the number of human neurological dis-
orders associated with sodium channel mutations.
We are likely to discover a heterogeneous group of
amino acid substitutions causing mild alterations
in channel properties, like the SCN1A mutations
in GEFS plus (Escayg et al., 2000). Because of the
critical role of sodium channels in neuronal sig-
naling, structural variants may also be suscepti-
bility factors in polygenic disease, including the
common psychiatric disorders, through genetic
interaction with subtle variants in other proteins.
We have identified rare coding variants of SCN1A,
SCN2A and SCN3A in 5% of patients with
familial autism (Weiss et al., 2003). Different
classes of neurons may vary in their susceptibility
to specific mutations, as we have seen for the
jolting mutation in Purkinje versus motor neurons.
The phenotypes of Scn8a mutant mice have
directed our attention to specific human patients
for mutation testing. We anticipate that at some
point in the future all admissions to neurological
or psychiatric services will be routinely screened
for channelopathies, using a sequencing chip that
can detect variation in all 10 sodium channel
genes. A wealth of information on structure/
function relationships will then become available.
Introduction of human disease mutations into the
orthologous mouse gene as transgenes or targeted
mutation will be useful for verifying causality and
for analysis of pathogenic mechanisms (Figure 4).
Recordings from neurons isolated from mutant
mice provide data about mutant channels that
goes beyond the information that can be obtained
from expression in Xenopus oocytes or transfected
mammalian cells. Crosses with mice carrying
mutations in other genes can reveal genetic inter-
actions and modifiers influencing clinical pheno-
types. Analysis of multiple alleles in the mouse can
provide a depth of understanding of in vivo gene
function that is otherwise unavailable.
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